Ha seleccionado la visión en Inglés
Descriptor en español: |
Levodopa
| ||||||
Descriptor en inglés: | Levodopa | ||||||
Descriptor en portugués: | Levodopa | ||||||
Descriptor en francés: | Lévodopa | ||||||
Término(s) alternativo(s): |
3 Hydroxy L tyrosine 3-Hydroxy-L-tyrosine Dopaflex Dopar L 3,4 Dihydroxyphenylalanine L Dopa L-3,4-Dihydroxyphenylalanine L-Dopa Larodopa Levopa |
||||||
Código(s) jeráquico(s): |
D02.092.311.200.480 D02.455.426.559.389.657.166.175.200.480 D12.125.072.050.685.400.500 D12.125.072.050.875.130.500 |
||||||
Identificador Único RDF: | https://id.nlm.nih.gov/mesh/D007980 | ||||||
Nota de alcance: | The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. |
||||||
Calificadores permitidos: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Acción Farmacológica: |
Antiparkinsonianos Dopaminérgicos |
||||||
Número de registro: | 46627O600J | ||||||
Indexación anterior: |
Dopa (1966-1974) |
||||||
Nota Pública de MeSH: | 75; was see DOPA 1972-74 |
||||||
Nota Online: | search DOPA 1972-74 |
||||||
Nota de historia: | 75; was see DOPA 1972-74 |
||||||
Vea también los descriptores: |
Dopamine
MeSH | ||||||
Identificador de DeCS: | 24230 | ||||||
ID del Descriptor: | D007980 | ||||||
Clasificación de la NLM: | WK 725 | ||||||
Documentos indizados en la Biblioteca Virtual de Salud (BVS): | Haga clic aquí para acceder a los documentos de la BVS | ||||||
Fecha de establecimiento: | 01/01/1975 | ||||||
Fecha de entrada: | 01/01/1999 | ||||||
Fecha de revisión: | 30/06/2018 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Levodopa
- Concepto preferido
Levopa
- Más estrecho
Larodopa
- Más estrecho
Dopaflex
- Más estrecho
Dopar
- Más estrecho
UI del concepto |
M0012434 |
Nota de alcance | The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. |
Término preferido | Levodopa |
Término(s) alternativo(s) |
3 Hydroxy L tyrosine 3-Hydroxy-L-tyrosine L 3,4 Dihydroxyphenylalanine L Dopa L-3,4-Dihydroxyphenylalanine L-Dopa |
UI del concepto |
M0351195 |
Término preferido | Levopa |
UI del concepto |
M0012435 |
Término preferido | Larodopa |
UI del concepto |
M0463388 |
Término preferido | Dopaflex |
UI del concepto |
M0463389 |
Término preferido | Dopar |
Queremos sus comentarios sobre el nuevo sitio web de DeCS / MeSH
Lo invitamos a completar una encuesta que no tomará más de 3 minutos.
Ir a la encuesta